Predicting quality of life of patients after treatment for spinal metastatic disease: development and internal evaluation.

Journal: The spine journal : official journal of the North American Spine Society
Published Date: Mar 26, 2025

Abstract

BACKGROUND CONTEXT: When treating spinal metastases in a palliative setting, maintaining or enhancing quality of life (QoL) is the primary therapeutic objective. Clinicians tailor their treatment strategy by weighing the QoL benefits against expected survival. To date, no available model exists that predicts QoL in patients after treatment for spinal metastases.

Authors

  • RenĂ© Harmen Kuijten
    Department of Radiation Oncology, University Medical Center Utrecht, Polikliniek Radiotherapie, UMC Utrecht, P.O. Box 85500, 3508 GA, Utrecht, the Netherlands.
  • Bas Bindels
    Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Olivier Groot
    Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Eline Huele
    Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Roxanne Gal
    Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Mark Groot
    Central Diagnostic Library, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Joanne van der Velden
    Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Diyar Delawi
    Department of Orthopedic Surgery, Antonius Medical Center, Koekoekslaan 1, Nieuwegein 3435 CM, The Netherlands.
  • Joseph Schwab
    Department of Orthopedic Surgery, Musculoskeletal Oncology Service, Massachusetts General Hospital, Harvard Medical School, Boston, Massachusetts, USA.
  • Helena Verkooijen
    Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands; Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Jorrit Jan Verlaan
    Department of Orthopedic Surgery, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands; Division of Imaging and Oncology, University Medical Center Utrecht, Utrecht University, Heidelberglaan 100, Utrecht 3584 CX, The Netherlands.
  • Daniel Tobert
    Department of Orthopedic Surgery, Orthopedic Spine Center and Orthopedic Oncology Service, Massachusetts General Hospital, Boston, MA, USA.
  • Joost Rutges
    Department of Orthopedics and Sports Medicine, Erasmus Medical Center, Doctor Molewaterplein 40, Rotterdam, 3015 GD, The Netherlands. Electronic address: j.rutges@erasmusmc.nl.

Keywords

External Resources

Popular Topics
Recent Journals